Summary
Gender surgeons who attended WPATH and USPATH conferences (meetings of trans health professionals) were asked how many patients they had seen who regretted surgery or wanted it reversed. Fewer than a third replied. Together they recalled 62 such patients out of an estimated 18,000 to 27,000 they had operated on, so the authors put regret at 0.2–0.3%. Where reasons were known, the most common was a change in gender identity or a wrong diagnosis, then family or social rejection, then relationship problems. The authors suggest sorting regret into three types: 'true gender-related', 'social' and 'medical'. This grouping is useful for discussion. But the regret figure cannot be trusted: it depends on surgeons' memory, on regretful patients going back to a surgeon, and on numbers from a self-selected minority who answered.
Key findings
- Odpowiedziało 46 ze 154 zaproszonych chirurgów (30%); większość pracowała w USA (67%) lub Europie (22%), a 65% praktykowało ponad 10 lat.
- Szacowali, że operowali 18 125 do 27 325 pacjentów transpłciowych i przypomnieli sobie 62, którzy żałowali operacji lub prosili o cofnięcie, czyli około 0,2–0,3%.
- 57% chirurgów widziało co najmniej jednego pacjenta z żalem; 45 z 62 przypadków (73%) dotyczyło operacji narządów płciowych, a 13 (21%) operacji klatki piersiowej lub piersi.
- Tam, gdzie powody były znane (46 pacjentów), 42% dotyczyło zmiany tożsamości płciowej lub błędnej diagnozy, 15% odrzucenia przez rodzinę lub społeczeństwo, a 11% problemów w związku.
- Autorzy podzielili prośby o cofnięcie na „prawdziwy związany z płcią” żal (42%), żal „społeczny” (37%) i żal „medyczny” (8%); 24% tych pacjentów miało powikłania po operacji.
- 91% chirurgów wymagałoby nowej oceny zdrowia psychicznego przed operacją cofającą, a 88% chciało, by następne wytyczne WPATH obejmowały operacje cofające.
- Autorzy przyznają, że ankiety słabo nadają się do ustalania, jak coś jest powszechne, i że ich przegląd wcześniejszych badań nie był systematyczny.
Abstract
Background: A rare, but consequential, risk of gender affirming surgery (GAS) is post-operative regret resulting in a request for surgical reversal. Studies on regret and surgical reversal are scarce, and there is no standard terminology regarding either etiology and/or classification of the various forms of regret. This study includes a survey of surgeons' experience with patient regret and requests for reversal surgery, a literature review on the topic of regret, and expert, consensus opinion designed to establish a classification system for the etiology and types of regret experienced by some patients.
Methods: This anonymous survey was sent to the 154 surgeons who registered for the 2016 World Professional Association for Transgender Health (WPATH) conference and the 2017 USPATH conference. Responses were analyzed using descriptive statistics. A MeSH search of the gender-affirming outcomes literature was performed on PubMed for relevant studies pertaining to regret. Original research and review studies that were thought to discuss regret were included for full text review.
Results: The literature is inconsistent regarding etiology and classification of regret following GAS. Of the 154 surgeons queried, 30% responded to our survey. Cumulatively, these respondents treated between 18,125 and 27,325 individuals. Fifty-seven percent of surgeons encountered at least one patient who expressed regret, with a total of 62 patients expressing regret (0.2-0.3%). Etiologies of regret were varied and classified as either: (I) true gender-related regret (42%), (II) social regret (37%), and (III) medical regret (8%). The surgeons' experience with patient regret and request for reversal was consistent with the existing literature.
Conclusions: In this study, regret following GAS was rare and was consistent with the existing literature. Regret can be classified as true gender-related regret, social regret and medical regret resulting from complications, function, pre-intervention decision making. Guidelines in transgender health should offer preventive strategies as well as treatment recommendations, should a patient experience regret. Future studies and scientific discourse are encouraged on this important topic.
Conclusion
In this study, regret following GAS was rare and was consistent with the existing literature. Regret can be classified as true gender-related regret, social regret and medical regret resulting from complications, function, pre-intervention decision making. Guidelines in transgender health should offer preventive strategies as well as treatment recommendations, should a patient experience regret. Future studies and scientific discourse are encouraged on this important topic.